Abstract
IntroductionThere are no established non-endoscopic evidence-based approaches to reduce the risk of malignant progression in patients with non-dysplastic Barrett’s oesophagus (BO), the only known precursor to oesophageal adenocarcinoma (OAC). Statins...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
